What to expect in your first month on a GLP‑1: a week-by-week guide
Starting semaglutide or tirzepatide comes with changes your body needs time to adjust to. Here is what to expect each week and when something needs medical attention.
Read More →GLP‑1 injection anxiety: building a calmer weekly shot routine
Feeling nervous before your GLP‑1 shot is common. Learn practical ways to make injection day calmer, more predictable, and easier to track.
Read More →Best foods to eat and avoid on GLP‑1 medications
What you eat on semaglutide or tirzepatide matters more than ever because appetite suppression means every calorie counts. Here are the foods that support your progress and the ones that cause problems.
Read More →Ozempic vs Wegovy vs Mounjaro vs Zepbound: how to compare GLP‑1 medications
Ozempic, Wegovy, Mounjaro, and Zepbound are the four most prescribed GLP‑1 medications on the market. This guide breaks down their active ingredients, approved uses, clinical trial results, and costs so you can have a more informed conversation with your provider.
Read More →GLP‑1 and constipation: why it happens and how to find relief
Constipation affects roughly 24 percent of people taking semaglutide at its highest dose, and unlike nausea it often persists throughout treatment. Here is why it happens and what actually helps.
Read More →What happens when you stop taking a GLP‑1 medication: the data on weight regain
Research consistently shows that most people regain approximately two-thirds of lost weight within a year of stopping a GLP‑1 medication. Here is what the data says, why it happens, and how to prepare.
Read More →GLP‑1 and menstrual changes: what women are reporting about their periods
Women on GLP‑1 medications are reporting heavier periods, irregular cycles, and unexpected fertility changes. A 2026 medRxiv study of 67,008 Reddit users flagged menstrual irregularities as an emerging signal. Here is what we know so far.
Read More →GLP‑1 medications and fertility: what women need to know
GLP‑1 medications can restore ovulation in women with PCOS and unexpectedly increase fertility through weight loss. Here is what the research says about conception planning, contraception, and safety.
Read More →How to store your GLP‑1 medication: refrigeration, travel, and expiration rules
Learn how to store your GLP‑1 pen correctly before and after first use, including refrigeration rules and expiration timelines.
Read More →How to switch between GLP‑1 medications safely
Switching from one GLP‑1 medication to another is common and does not require a washout period. Learn why patients switch, how providers approach the transition, and what to expect.
Read More →GLP‑1 dose schedules explained: titration, maintenance, and what to expect at each level
Every GLP‑1 medication follows a specific titration schedule designed to minimize side effects. Here is a complete breakdown of dose levels, timelines, and what happens at each step.
Read More →Best exercises while on GLP‑1 medications: what to do and when
Many GLP‑1 users actually decrease physical activity after starting medication. Here is why exercise matters more, not less, on these drugs and what types deliver the best results.
Read More →Is compounded semaglutide safe: what you need to know
Compounded semaglutide is not FDA-approved and lacks the same quality controls as brand-name medications. Learn the risks, cost differences, and what changed after the semaglutide shortage ended.
Read More →Next-generation weight loss medications: retatrutide, CagriSema, and what is coming in 2027
Several next-generation obesity medications are approaching FDA decisions, including retatrutide with 28.7 percent weight loss in Phase 3 and CagriSema with 22.7 percent. Here is what the pipeline looks like heading into 2027.
Read More →GLP‑1 and fatigue: why you feel tired and what helps
Fatigue affects about 11 percent of semaglutide users in clinical trials and is often linked to reduced calorie intake, dehydration, or protein deficiency. Learn why it happens and how to manage it.
Read More →GLP‑1 and acid reflux: managing heartburn and GERD on treatment
Acid reflux and GERD affect 9 to 15 percent of GLP‑1 users in clinical trials, driven by delayed gastric emptying. Learn why it happens, what makes it worse, and how to manage it effectively.
Read More →